MDM2 and Miyoshi myopathy: We acknowledge that MX69 may have off-target effects, independent of MDM2, leading to further MM growth inhibition; future studies are warranted to fully elucidate such additional targets and possible other mechanisms underlying MX69′s anti-cancer properties.